Barings’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-629
| Closed | -$351K | – | 427 |
|
|
2021
Q2 | $351K | Sell |
629
-54
| -8% | -$30.1K | 0.01% | 339 |
|
|
2021
Q1 | $323K | Buy |
683
+17
| +3% | +$8.04K | 0.01% | 361 |
|
|
2020
Q4 | $322K | Sell |
666
-5,252
| -89% | -$2.54M | 0.01% | 339 |
|
|
2020
Q3 | $3.31M | Buy |
5,918
+2,762
| +88% | +$1.55M | 0.08% | 180 |
|
|
2020
Q2 | $1.54M | Hold |
3,156
| – | – | 0.05% | 225 |
|
|
2020
Q1 | $1.54M | Sell |
3,156
-439
| -12% | -$214K | 0.05% | 225 |
|
|
2019
Q4 | $1.34M | Sell |
3,595
-670
| -16% | -$250K | 0.04% | 308 |
|
|
2019
Q3 | $1.18M | Buy |
4,265
+1
| +0% | +$277 | 0.03% | 341 |
|
|
2019
Q2 | $1.34M | Buy |
4,264
+157
| +4% | +$49.2K | 0.03% | 331 |
|
|
2019
Q1 | $1.69M | Buy |
4,107
+2,380
| +138% | +$977K | 0.04% | 311 |
|
|
2018
Q4 | $645K | Hold |
1,727
| – | – | 0.01% | 448 |
|
|
2018
Q3 | $698K | Hold |
1,727
| – | – | 0.01% | 550 |
|
|
2018
Q2 | $596K | Buy |
+1,727
| New | +$596K | 0.01% | 601 |
|
|
2016
Q1 | – | Sell |
-710
| Closed | -$385K | – | 965 |
|
|
2015
Q4 | $385K | Hold |
710
| – | – | 0.01% | 715 |
|
|
2015
Q3 | $330K | Sell |
710
-620
| -47% | -$288K | 0.01% | 732 |
|
|
2015
Q2 | $678K | Sell |
1,330
-1,660
| -56% | -$846K | 0.02% | 613 |
|
|
2015
Q1 | $1.35M | Buy |
2,990
+2,040
| +215% | +$921K | 0.03% | 422 |
|
|
2014
Q4 | $390K | Hold |
950
| – | – | 0.01% | 720 |
|
|
2014
Q3 | $342K | Hold |
950
| – | – | 0.01% | 756 |
|
|
2014
Q2 | $268K | Hold |
950
| – | – | 0.01% | 860 |
|
|
2014
Q1 | $285K | Hold |
950
| – | – | 0.01% | 801 |
|
|
2013
Q4 | $261K | Hold |
950
| – | – | 0.01% | 789 |
|
|
2013
Q3 | $297K | Buy |
+950
| New | +$297K | 0.01% | 765 |
|